MOESM4 of Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

Huber, Sara; Lang, Roland; Steiner, Markus; Aglas, Lorenz; Ferreira, Fatima; Wallner, Michael; Hawranek, Thomas; Gadermaier, Gabriele

doi:10.6084/m9.figshare.7177208.v1

13601_2018_226_MOESM4_ESM.pdf (394.98 kB)

MOESM4 of Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

journal contribution

posted on 2018-10-08, 05:00 authored by Sara Huber, Roland Lang, Markus Steiner, Lorenz Aglas, Fatima Ferreira, Michael Wallner, Thomas Hawranek, Gabriele Gadermaier

Additional file 4. Mediator release curves of RBL-2H3 cells during birch pollen AIT and correlation with antibody titer.

Funding

Ăsterreichische ForschungsfĂśrderungsgesellschaft

History

Usage metrics

Keywords

Birch pollen Blocking capacity Immunotherapy Bet v 1 IgE FAB assay Inhibition mediator release assay Allergens and epitopes

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM4 of Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

Funding

Ăsterreichische ForschungsfĂśrderungsgesellschaft

History

Usage metrics

Categories

Keywords

Licence

Exports

Ăsterreichische ForschungsfĂśrderungsgesellschaft